Funding


Currently Held


NSERC_logo

NSERC

NSERC Operating Grant (2014-2019) – Role of Tuberin in Cell Cycle Progression through G2/M.


CRS_logo

The Cancer Research Society

Cancer Research Society (2014-2016) – Resolving the Growth Properties of Glioma Stem Cells – Co-applicant Dr. Ana Carvalho.


logo_ccs

CCSRI

CCSRI Innovation to Impact Grant – (2015-2018). Role of Spy1 in Driving Brain Tumour Initiating Cells.


CIHR

CIHR Operating Grant – (2015-2020). Novel Cell cycle Regulation in the Initiation and Therapeutic Intervention of Triple Negative Breast Cancer.  Co-Applicant – Dr. Caroline Hamm


Brain Tumour Foundation of Canada

BTFC Operating Grant – (2015). Optimizing Novel Therapeutics for Medulloblastoma.


Previously Held


  • CCSRI Innovation Grant – (2013-2015). Role of Spy1 in Neurogenesis: Implications in the initiation and progression of Glioma. co-applicant – Dr. Eran Andrechek.
  • Seeds 4 Hope, Seed grant WECCF (2012-2014) – Role of Spy1 in multiple myeloma.
  • Seeds 4 Hope, Seed grant WECCF (2012-2014) – co-applicant (lead – Dr. Elizabeth Fidalgo da Silva). The Role of Tuberin in the Development and Progression of Pediatric Brain Tumours.
  • Seeds 4 Hope, Seed grant WECCF (2012-2014) – co-applicant (lead – Dr. Dora Cavallo Medved) Caveolin-1 Mediates Proteolysis and Invasion in the Tumour Microenvironment of Prostate Cancer.
  • Seeds 4 Hope, Seed grant WECCF (2012-2014) – co-applicant (lead – Dr. Michael Boffa). Is TAF1 a novel anti-metastatic factor in breast cancer.
  • Canadian Cancer Society/Canadian Breast Cancer Research Alliance Operating Grant – 2009-2014 – Role of Spy1 in Mammary Gland Development.
  • Seeds 4 Hope, Seed grant WECCF (2010-2012) co-applicant (lead PI Dr. Caroline Hamm) – Phase II trial with carboplatin in addition to dose dense ACT in women with triple negative breast cancer; Testing for novel prognostic biomarkers.
  • Seeds 4 Hope, Seed grant WECCF (2010-2012) co-applicant (lead PI Dr. Bulent Mutus) – Role of neutral Sphingomyelase 2 can lead to breast cancer cell survival through hormone receptor stabilization on plasma membrane cholesterol rafts.
  • Canadian Institutes of Health Research/ Canadian Breast Cancer Research Alliance Salary Award (2006-2011) – Role of Spy1 in Mammary Gland Development.
  • NSERC Research Tools and Instruments (Cat. 1) (2010) – Multi-User Microscopy System for High Resolution cell Biology/Biochemistry Imaging.
  • Seeds 4 Hope, Seed grant WECCF (2009-2011) – Stress Factor Signaling in Breast Cancer.
  • Seeds 4 Hope, Seed grant WECCF (2009-2011) co-applicant (lead PI Dr. Dora Cavallo-Medved) – Role of the Cathepsin Family of Proteases in Inflammatory Breast Cancers.
  • Cancer Research Society (2008-2010) – Role of Spy1 in Cellular Senescence.
  • Canadian Institutes of Health Research/ Canadian Breast Cancer Research Alliance Operating Grant (2006-2009) – Role of Spy1 in Mammary Gland Development.
  • Local Investigator Research Fund; Windsor Regional Cancer Center – renewal application (2007) – Stress Effects on Breast Cell Growth and Morphogenesis; Implications in the Treatment of Breast Cancer Patients.
  • NSERC Research Tools and Instruments (Cat. 1) (2007) – Confocal Microscope for Multichannel and Live Imaging.
  • NSERC Research Tools and Instruments (Cat. 1) (2007) – Aquatic Facility for Research Animals.
  • Cancer Research Society Operating Grant (2005-2007) – Role of Spy1 in Breast Cell Senescence.
  • NSERC Research Tools and Instruments (Cat. 1) (2005) – co-PI – Multi-User Confocal Upgrade.
  • NSERC Research Tools and Instruments (Cat. 1) (2006) – lead PI – Multi-User Gel Documentation System.
  • NSERC Research Tools and Instruments (Cat. 1) (2006) – co-PI – Analytical Core Upgrade.
  • NSERC Research Tools and Instruments (Cat. 1) – 2006 – co-PI – Multi-user Cryostorage Facility.
  • Local Investigator Research Fund; Windsor Regional Cancer Center (2006) – Stress Effects on Breast Cell Growth and Morphogenesis; Implications in the Treatment of Breast Cancer Patients.
  • CFI/ORF (2006) – Cell Culture/Viral Preparation Suite.